Viora companion index
Drug companion guides
General lifestyle information for people starting GLP-1s and related weight-management medications. Not medical advice — always follow your prescriber's instructions.
Prescription medications
AOD-9604
A synthetic fragment of human growth hormone (hGH176-191) investigated for its potential effects on fat metabolism.
Open protocol →
BPC-157
Synthetic gastric-derived peptide investigated in regeneration and GI models.
Open protocol →
CagriSema (combination)
Cagrilintide
A long-acting amylin analogue under clinical investigation for weight management, including in combination with semaglutide.
Open protocol →
Forzinity
Elamipretide
A mitochondria-targeted tetrapeptide, also known as elamipretide, approved in the U.S. as Forzinity for a narrow Barth syndrome indication.
Open protocol →
Mazdutide
A dual GLP-1 / glucagon receptor agonist under clinical development for weight management and metabolic disease.
Open protocol →
Mounjaro
Tirzepatide
A dual GLP-1 / GIP receptor agonist prescribed for type 2 diabetes management.
Open protocol →
Ozempic
Semaglutide
A GLP-1 receptor agonist primarily indicated for type 2 diabetes management, also prescribed off-label for weight management.
Open protocol →
Retatrutide
A triple receptor agonist (GLP-1, GIP, glucagon) in late-stage clinical development for obesity and metabolic disease.
Open protocol →
Saxenda
Liraglutide
A GLP-1 receptor agonist prescribed for chronic weight management in adults and adolescents.
Open protocol →
Wegovy
Semaglutide
A GLP-1 receptor agonist prescribed for chronic weight management in adults.
Open protocol →
Zepbound
Tirzepatide
A dual GLP-1 / GIP receptor agonist approved for chronic weight management.
Open protocol →
Investigational peptides
Not approved for human therapeutic use. Research context only.
5-Amino-1MQ
NNMT inhibitor
A small-molecule NNMT inhibitor studied in metabolic and NAD+ biology, mostly in preclinical and early research settings.
Open protocol →
Epitalon (Epithalon)
Synthetic tetrapeptide
A synthetic tetrapeptide studied for telomerase, circadian, and geroprotective biology in preclinical and limited human literature.
Open protocol →
MOTS-c
Mitochondrial-derived peptide
A mitochondrial-derived peptide studied for AMPK-linked metabolic regulation, insulin sensitivity, and exercise/metabolic adaptation in preclinical research.
Open protocol →
NAD+
Cellular coenzyme
A cellular redox coenzyme involved in energy metabolism, DNA repair, and mitochondrial function; injectable protocols are typically compounded or research-context references.
Open protocol →